Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 44,300 shares, an increase of 6.7% from the January 15th total of 41,500 shares. Based on an average trading volume of 124,500 shares, the days-to-cover ratio is presently 0.4 days.
Analyst Upgrades and Downgrades
Separately, Citigroup upgraded Fresenius SE & Co. KGaA to a “strong-buy” rating in a research report on Friday, October 25th.
Check Out Our Latest Report on Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Stock Down 2.1 %
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Recommended Stories
- Five stocks we like better than Fresenius SE & Co. KGaA
- How to Invest in Biotech Stocks
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- What is the Dow Jones Industrial Average (DJIA)?
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- What is the Hang Seng index?
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.